Oregon Public Employees Retirement Fund Trims Stake in CME Group Inc. $CME

Oregon Public Employees Retirement Fund cut its stake in CME Group Inc. (NASDAQ:CME) by 0.3% in the second quarter, HoldingsChannel reports. The fund owned 31,128 shares of the financial services provider’s stock after selling 83 shares during the period. Oregon Public Employees Retirement Fund’s holdings in CME Group were worth $8,579,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Webster Bank N. A. lifted its stake in shares of CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 60 shares during the period. Highline Wealth Partners LLC increased its stake in shares of CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares in the last quarter. Wayfinding Financial LLC purchased a new position in shares of CME Group in the 1st quarter valued at about $25,000. Cornerstone Planning Group LLC boosted its position in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 55 shares in the last quarter. Finally, Trifecta Capital Advisors LLC grew its holdings in CME Group by 59.2% in the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 42 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft decreased their target price on CME Group from $276.00 to $266.00 and set a “hold” rating on the stock in a research report on Thursday. UBS Group dropped their target price on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a research report on Monday, September 8th. Morgan Stanley lifted their price objective on CME Group from $303.00 to $312.00 and gave the stock an “overweight” rating in a report on Wednesday, October 1st. Piper Sandler boosted their price target on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Finally, Barclays lowered their target price on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $281.00.

CME Group Price Performance

CME stock opened at $271.45 on Monday. The business has a fifty day moving average of $268.89 and a two-hundred day moving average of $271.29. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market cap of $97.83 billion, a price-to-earnings ratio of 26.28, a price-to-earnings-growth ratio of 5.72 and a beta of 0.41. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.56 EPS. As a group, research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s payout ratio is 48.40%.

Insider Activity at CME Group

In other news, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. The trade was a 4.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is owned by insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.